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Historical Overview
• The Nuremberg Code
• The Declaration of Helsinki
• The Belmont Report
• The Common Rule
Nuremberg Code
• End of WWII
• Prosecution of Nazi Physicians and Scientists
• The Tribunal drafted a set of 10 ethical 
principles for inclusion of humans in research
• Basic Tenant: Participation as a research 
subject in any medical experiment must be 
voluntary
Declaration of Helsinki
• Drafted by the World Medical Association 
(1964, last updated in 2000)
• Next step toward creation of standard ethical 
guidelines
• Has become the basis for Good Clinical 
Practices (GCPs) that are used today
Research Abuses in the US
• Radiation Experiments (1940-1960s)
• Willowbrook Hepatitis Study (1963-1966)
• Public Health Services Syphilis Study (1932-
1972)
Responses to Research Abuses
• Congress enacted the National Research Act in 
1974 as a result of the publicity from the 
Tuskegee syphilis study
National Research Act
• Created the National Commission for the 
Protection of Human Subjects of Biomedical 
and Behavioral Research
• Goal of the Commission: Conduct a 
comprehensive investigation to identify the 
basic ethical principles that should underlie 
the conduct of research involving human 
subjects
National Commission Reports
• Research on the fetus (1975)
• Research involving prisoners (1976)
• Research involving children (1977)
• Institutional Review Boards (1978)
• Delivery of Health Services (1978)
• Research involving mentally infirm (1978)
• The Belmont Report (1979)
Belmont Report
• Cornerstone for the principles and regulations 
governing the ethical conduct of research in 
the US involving human subjects
• Written in 1979 by the National Commission 









– Respect for individuals as autonomous agents
– Requires additional protections for those with 
diminished autonomy
• Clinical Applications
– Informed Consent must include
• Disclosure of information about the research
• Tailoring the information to an individual’s ability to 
comprehend
• Assuring that the consent process occurs in an environment 
free of coercion and undue influence
Belmont Report
• Beneficence
– Research subjects should not be harmed
– Research should maximize benefits and minimize 
harms
• Clinical Applications
– Research should begin only after the expected 
benefits outweigh the anticipated harms
Belmont Report
• Justice
– Benefits and risks should be distributed fairly
• Clinical Applications
– Equitable selection of subjects
Protection of Human 
Research Subjects
• 1974: Regulations protecting human research 
subjects became effective in the United States
• 1981: Significant revisions of the regulations 
by both the DHHS and FDA
• 1991: Revision involved adoption of the 
Federal Policy for the Protection of Human 
Subjects (the Common Rule: 45 CFR 46)
FDA Regulations
• 1980: The FDA adopted many of the 
provisions of the common rule (21 CFR 50 and 
56)
• 1991: Final revision to 21 CFR 50 and 56
Additional Protections
• 45 CFR 46, Subpart A (vulnerable subjects in 
general)
• 45 CFR 46, Subpart B (pregnant women, 
fetuses)
• 45 CFR 46, Subpart C (prisoners)
• 45 CFR 46, Subpart D (children)
• 21 CFR 50, Subpart D (children)
Institutional Review Boards
• “Investigators should not have the sole 
responsibility for determining whether 
research involving human subjects fulfills 
ethical standards.  Others who are 
independent of the research must share the 
responsibility.” 
National Commission Report on IRBs, 1978
Responsibilities of the IRB
• Approve, disapprove, or require modifications 
of research
• Conduct continuing review of IRB approved 
research
• Observe/monitor/audit on-going research
• Suspend or terminate approval of research
45 CFR 109
21 CFR 56.109
Authority of the IRB
• 45 CFR 46
• 21 CFR 50 and 56
• 21 CFR 312 
• 21 CFR 812
• Institutional Policies
• Federal Wide Assurance
IRB Criteria to Approve Research
• Risks to subjects are minimized (B)
• Risks to subjects are reasonable in relation to the 
anticipated benefits (B)
• Selection of subjects is equitable (J)
• Safety monitoring is in place (B)
• Privacy and confidentiality are maintained (B)
• The informed consent process is appropriate (R)
• Informed consent is appropriately documented (R)
• Additional protections for vulnerable subjects are in 
place (R,B)
Research Protection at LVH
• Comprehensive HRPP
• Support from the “Institution”
• Research Participant Protection Program
• Two Institutional Review Boards

Overview of the Human Research 
Protection Program
• The HRPP is the institution’s (LVHHN’s) 
program to protect our research participants
• The supporting entity of the HRPP is the 
Research Participant Protection Office (RPPO)
• The IRB Office is a component of the RPPO
Overview of the HRPP
Chief Medical 
Officer














• Each committee meets monthly
• Each IRB reviews all types of research
